MediPress Health-Limited Partnership (MPRS.TA)
Tel Aviv · ILA · Healthcare · Medical Devices
ILA 51.30 (-1.35%) as of
Key statistics
- Dividend yield
- 0.00%
- 52-week range
- 0.53 – 75.70
- Profit margin
- 0.00%
- Volume
- 36.78k
About MediPress Health-Limited Partnership
MediPress Health-Limited Partnership, is a research and development life science partnership and venture capital firm specializing in seed/startups investments. The firm seeks to invest in medical research and development companies. Its portfolio companies engage in the treatment of cancer with proton radiation therapy; and the development of non-surgical vaginal solutions for women with various pelvic floor disorders. The firm seeks to take board positions in its portfolio companies. MediPress Health-Limited Partnership was incorporated in 2021 and is based in Ramat Gan, Israel.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Ramat Gan, Israel
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.